DRREDDY
2600
2019-01-04
DR.REDDY'S LABORATORIES LTD.
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.5393 0.6335
Current ratio 2.82 2
WC days 206.45 123.67
EBITDA (%) 16.37 17.78
FCF (Rs Cr.) 54 -123
ROCE (%) 5.27 8.29
ROE (%) 4.79 7.53

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.04 0.05
Div. payout (%) 58.53 35.05
Int. Coverage 12.23 18.74
LT D/E 0.22 0.4
Solvency Ratio 0.52 0.4

Valuation STANDALONE CONSOLIDATED
Beta 0.3828 0.3828
Div. yield (%) 1 1
EV (Rs Cr.) 37036 39375.9
P/BV 2.93 2.75
P/E 61.08 36.54
PEG 6.29 0
P/S 3.69 2.42

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 711.27 757.29
3Y growth BV/s (%) 14 31
Cash (Rs Cr.) 120.7 263.8
Total Debt (Rs Cr.) 2588 5071
Net block (Rs Cr.) 4717 6968

P&L metrics STANDALONE CONSOLIDATED
DPS 19.96 19.97
EPS 34.1 56.99
Net Income (Rs Cr.) 566 946
Operating profit (Rs Cr.) 1330 2352
No. of o/s shares 16.6 16.6
Revenue (Rs Cr.) 9359 14281
Total Income (Rs Cr.) 9563 14436

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 9265 10861
3Y growth CEPS -0.12 -0.27
CFF (Rs Cr.) -304 -444
CFI (Rs Cr.) -1180 -1482
CFO (Rs Cr.) 1538 1803
FCF (Rs Cr.) 54 -123
3Y growth Op. CF (%) -14 -29

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) 0 0
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) -41 -33
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) -65 -58
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) -66 -60
1Y growth Op. CF (%) 51 -16
1Q growth revenue (%) 0 0
3Y growth revenue (%) -7 -5
4Q growth revenue (%) 0 0